Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model

Robles-Valero, JavierFernández-Nevado, LucíaCuadrado, MyriamLorenzo-Martín, L. FranciscoFernández-Pisonero, IsabelAbad, AntonioRedín, EstherMontuenga, LuisMartín-Zanca, DionisioBigas Salvans, AnnaMallo, MoisesDosil, MercedesBustelo, Xose R.2023-02-072023-02-072022Robles-Valero J, Fernández-Nevado L, Cuadrado M, Lorenzo-Martín LF, Fernández-Pisonero I, Abad A, Redín E, Montuenga L, Martín-Zanca D, Bigas A, Mallo M, Dosil M, Bustelo XR. Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model. Mol Oncol. 2022 Oct;16(19):3533-53. DOI: 10.1002/1878-0261.132951574-7891http://hdl.handle.net/10230/55662Mutations in the VAV1 guanine nucleotide exchange factor 1 have been recently found in peripheral T cell lymphoma and nonsmall-cell lung cancer (NSCLC). To understand their pathogenic potential, we generated a gene-edited mouse model that expresses a VAV1 mutant protein that recapitulates the signalling alterations present in the VAV1 mutant subclass most frequently found in tumours. We could not detect any overt tumourigenic process in those mice. However, the concurrent elimination of the Trp53 tumour suppressor gene in them drives T cell lymphomagenesis. This process represents an exacerbation of the normal functions that wild-type VAV1 plays in follicular helper T cells. We also found that, in combination with the Kras oncogene, the VAV1 mutant version favours progression of NSCLC. These data indicate that VAV1 mutations play critical, although highly cell-type-specific, roles in tumourigenesis. They also indicate that such functions are contingent on the mutational landscape of the tumours involved.application/pdfeng© 2022 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse modelinfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1002/1878-0261.13295RAC1TP53Angioimmunoblastic T cell lymphomaFollicular helper T cellsNonsmall-cell lung cancerPeripheral T cell lymphomainfo:eu-repo/semantics/openAccess